Page last updated: 2024-08-16

pioglitazone and sb 216763

pioglitazone has been researched along with sb 216763 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartolini, M; Bolognesi, ML; Campillo, NE; Castellano, S; Feoli, A; Gandini, A; Legname, G; Martinez, A; Martinez-Gonzalez, L; Miti, A; Moda, F; Monti, B; Perez, C; Petralla, S; Roca, C; Rossi, M; Tedesco, D; Zaldivar-Diez, J; Zuccheri, G	1

Other Studies

1 other study(ies) available for pioglitazone and sb 216763

Article	Year
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17 Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Central Nervous System Agents; Circular Dichroism; Drug Design; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; Glycogen Synthase Kinase 3; Hep G2 Cells; Humans; Microscopy, Atomic Force; Molecular Targeted Therapy; Okadaic Acid; Phosphorylation; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship; Swine; tau Proteins; Thiazolidinediones	2018

Article

Year

Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors.

Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17

Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Central Nervous System Agents; Circular Dichroism; Drug Design; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; Glycogen Synthase Kinase 3; Hep G2 Cells; Humans; Microscopy, Atomic Force; Molecular Targeted Therapy; Okadaic Acid; Phosphorylation; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship; Swine; tau Proteins; Thiazolidinediones

2018